Brokers Offer Predictions for Elutia FY2025 Earnings

Elutia Inc. (NASDAQ:ELUT) – Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Elutia in a research note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn anticipates that the company will earn ($0.95) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating and a $10.00 target price on the stock. The consensus estimate for Elutia’s current full-year earnings is ($1.76) per share.

Elutia Stock Performance

ELUT stock opened at $3.25 on Wednesday. Elutia has a 52-week low of $2.28 and a 52-week high of $5.24. The company has a market capitalization of $112.33 million, a P/E ratio of -1.25 and a beta of 0.89. The company has a fifty day moving average price of $3.90 and a 200-day moving average price of $3.83.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Arcus Capital Partners LLC grew its position in shares of Elutia by 100.0% during the 3rd quarter. Arcus Capital Partners LLC now owns 20,000 shares of the company’s stock worth $76,000 after buying an additional 10,000 shares during the period. Renaissance Technologies LLC grew its holdings in Elutia by 50.5% in the second quarter. Renaissance Technologies LLC now owns 53,616 shares of the company’s stock worth $266,000 after purchasing an additional 18,000 shares during the period. Geode Capital Management LLC increased its stake in Elutia by 50.3% in the third quarter. Geode Capital Management LLC now owns 188,408 shares of the company’s stock valued at $718,000 after purchasing an additional 63,047 shares in the last quarter. Perkins Capital Management Inc. raised its holdings in shares of Elutia by 9.8% during the third quarter. Perkins Capital Management Inc. now owns 856,552 shares of the company’s stock valued at $3,263,000 after purchasing an additional 76,450 shares during the period. Finally, Nantahala Capital Management LLC boosted its position in shares of Elutia by 8.8% during the 2nd quarter. Nantahala Capital Management LLC now owns 1,795,697 shares of the company’s stock worth $8,907,000 after purchasing an additional 145,697 shares in the last quarter. Institutional investors and hedge funds own 74.03% of the company’s stock.

About Elutia

Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.